FibroBiologics
FBLG
52 hedge funds and large institutions have $3.28M invested in FibroBiologics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 13 closing their positions.
0.14% less ownership
Funds ownership: 0.78% → 0.64% (-0.14%)
9% less funds holding
Funds holding: 57 → 52 (-5)
12% less capital invested
Capital invested by funds: $3.75M → $3.28M (-$467K)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$210K |
| 2 |
GS
GTS Securities
New York
|
+$185K |
| 3 |
Renaissance Technologies
New York
|
+$35.8K |
| 4 |
P
&Partners
Nashville,
Tennessee
|
+$18K |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
-$200K |
| 2 |
BlackRock
New York
|
-$186K |
| 3 |
Goldman Sachs
New York
|
-$72.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66K |
| 5 |
Jane Street
New York
|
-$59.8K |
FBLG Hedge Fund Activity: Q3 2025 in Review
52 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2025, worth a combined $3.28M — down 12% from $3.75M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of FBLG and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 9 added.
The largest buyer was Landscape Capital Management, opening a new position worth an estimated $210K. The largest seller was Yorkville Advisors Global, cutting an estimated $200K.
- 52 institutional investors held FibroBiologics (FBLG) as of Q3 2025, down from 57 in Q2 2025.
- Funds reported $3.28M of FibroBiologics stock for Q3 2025, down 12% quarter-over-quarter.
- 8 funds opened new FibroBiologics positions in Q3 2025 and 13 closed out, a net change of -5 holders.
- The largest FibroBiologics buyer in Q3 2025 was Landscape Capital Management, an estimated $210K added.
- The largest FibroBiologics seller in Q3 2025 was Yorkville Advisors Global, an estimated $200K sold.
Based on aggregated 13F filings for Q3 2025.